Crystal structure of ClfA in complex with the Fab fragment of Tefibazumab
External Resource: Annotation
| Chains | Type | Family Name | Domain Identifier | Family Identifier | Provenance Source (Version) |
| A | SCOP2B Superfamily | Bacterial adhesin-like | 8033058 | 3000723 | SCOP2B (2022-06-29) |
| A | SCOP2B Superfamily | Bacterial adhesin-like | 8033056 | 3000723 | SCOP2B (2022-06-29) |
| Chains | Family Name | Domain Identifier | Architecture | Possible Homology | Homology | Topology | Family | Provenance Source (Version) |
| A | PRK | e5jq6A1 | A: a/b three-layered sandwiches | X: MocoBD/DmpA-related | H: profilin-like | T: profilin-like | F: PRK | ECOD (v294.1) |
| B [auth H] | PRK | e5jq6H1 | A: a/b three-layered sandwiches | X: MocoBD/DmpA-related | H: profilin-like | T: profilin-like | F: PRK | ECOD (v294.1) |
| C [auth L] | PRK | e5jq6L1 | A: a/b three-layered sandwiches | X: MocoBD/DmpA-related | H: profilin-like | T: profilin-like | F: PRK | ECOD (v294.1) |
| Chain | Protein Name | Description | Organism Name | Gene Allele Name(s) | Domain Name(s) | Receptor Type | Receptor Description | Provenance Source |
|---|
| B [auth H] | Fab Tefibazumab | VH-CH1 | Chimeric (chimeric) | IGHV2-6-4*01, IGHJ3*01, IGHG1*03, IGHG1*08, IGHG1*06 | V-DOMAIN VH, C-DOMAIN CH1 | IG | FAB-GAMMA-1_KAPPA | IMGT (202613-0) |
| C [auth L] | Fab Tefibazumab | L-KAPPA | Chimeric (chimeric) | IGKV8-27*01, IGKJ2*01, IGKC*01 | V-DOMAIN V-KAPPA, C-DOMAIN C-KAPPA | IG | FAB-GAMMA-1_KAPPA | IMGT (202613-0) |
| Chain | Chain Class | Chain Subclass | Chain Type | Antigen Name(s) | Provenance Source |
|---|
| B [auth H] | Heavy Chain | IGHV2 | - | clumping factor a | SAbDab (2026-04-10) |
| C [auth L] | Light Chain | IGKV8 | Kappa | clumping factor a | SAbDab (2026-04-10) |
| Chains | Polymer | Molecular Function | Biological Process | Cellular Component |
|---|
| Clumping factor A | - | | - |
| B [auth H] | Tefibazumab FAB FRAGMENT HEAVY CHAIN | - | - | - |
| C [auth L] | Tefibazumab FAB FRAGMENT LIGHT CHAIN | - | - | - |